{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:53:49Z","timestamp":1761652429375,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.7759\/cureus.95576","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:49:20Z","timestamp":1761652160000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular Characterization of KPC-2 and CMY AmpC Beta Lactamases in Ceftazidime-Avibactam Resistant Klebsiella pneumoniae in a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Usama","family":"Haseeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samana","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faryal","family":"Yunus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masham","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/S1517-838246320140138","article-title":"Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates","volume":"46","author":"Hou XH","year":"2015","unstructured":"Hou XH, Song XY, Ma XB, Zhang SY, Zhang JQ. Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates. Braz J Microbiol. 2015, 46:759-68. 10.1590\/S1517-838246320140138","journal-title":"Braz J Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01891-8","article-title":"ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro","volume":"10","author":"Daruka L","year":"2025","unstructured":"Daruka L, Czikkely MS, Szili P, et al.. ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. Nat Microbiol. 2025, 10:313-31. 10.1038\/s41564-024-01891-8","journal-title":"Nat Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.009","article-title":"Antimicrobial resistance comparison of Klebsiella pneumoniae pathogens isolated from intra-abdominal and urinary tract infections in different organs, hospital departments and regions of China between 2014 and 2017","volume":"54","author":"Zhang H","year":"2021","unstructured":"Zhang H, Zhang G, Yang Y, et al.. Antimicrobial resistance comparison of Klebsiella pneumoniae pathogens isolated from intra-abdominal and urinary tract infections in different organs, hospital departments and regions of China between 2014 and 2017. J Microbiol Immunol Infect. 2021, 54:639-48. 10.1016\/j.jmii.2020.03.009","journal-title":"J Microbiol Immunol Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S397975","article-title":"Molecular and clinical characteristics of carbapenem-resistant klebsiella pneumoniae isolates at a tertiary hospital in Wuhan, China","volume":"16","author":"Hu F","year":"2023","unstructured":"Hu F, Lin ML, Mou JL, et al.. Molecular and clinical characteristics of carbapenem-resistant klebsiella pneumoniae isolates at a tertiary hospital in Wuhan, China. Infect Drug Resist. 2023, 16:65-76. 10.2147\/IDR.S397975","journal-title":"Infect Drug Resist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-03987-5","article-title":"Drug resistant Klebsiella pneumoniae from patients and hospital effluent: a correlation?","volume":"25","author":"Masalane NS","year":"2025","unstructured":"Masalane NS, Bester LA, Ismail A, Essack SY, Mbanga J. Drug resistant Klebsiella pneumoniae from patients and hospital effluent: a correlation?. BMC Microbiol. 2025, 25:284. 10.1186\/s12866-025-03987-5","journal-title":"BMC Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"P\u00e9rez-P\u00e9rez FJ","year":"2002","unstructured":"P\u00e9rez-P\u00e9rez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002, 40:2153-62. 10.1128\/JCM.40.6.2153-2162.2002","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060731","article-title":"The rapid emergence of ceftazidime-avibactam resistance mediated by kpc variants in carbapenem-resistant Klebsiella pneumoniae in Zhejiang Province, China","volume":"11","author":"Liu C","year":"2022","unstructured":"Liu C, Wu Y, Huang L, et al.. The rapid emergence of ceftazidime-avibactam resistance mediated by kpc variants in carbapenem-resistant Klebsiella pneumoniae in Zhejiang Province, China. Antibiotics (Basel). 2022, 11:731. 10.3390\/antibiotics11060731","journal-title":"Antibiotics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.757470","article-title":"Emergence of ceftazidime\/avibactam and tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae due to in-host microevolution","volume":"11","author":"Han X","year":"2021","unstructured":"Han X, Shi Q, Mao Y, et al.. Emergence of ceftazidime\/avibactam and tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae due to in-host microevolution. Front Cell Infect Microbiol. 2021, 11:757470. 10.3389\/fcimb.2021.757470","journal-title":"Front Cell Infect Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1244511","article-title":"Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between bla(KPC-2) and bla(KPC-145) during treatment of Klebsiella pneumoniae infection","volume":"13","author":"Chen Y","year":"2023","unstructured":"Chen Y, Yang R, Guo P, et al.. Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between bla(KPC-2) and bla(KPC-145) during treatment of Klebsiella pneumoniae infection. Front Cell Infect Microbiol. 2023, 13:1244511. 10.3389\/fcimb.2023.1244511","journal-title":"Front Cell Infect Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28052","article-title":"A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: thirty years of development in Pakistan","volume":"10","author":"Umair M","year":"2024","unstructured":"Umair M, Walsh TR, Mohsin M. A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: thirty years of development in Pakistan. Heliyon. 2024, 10:e28052. 10.1016\/j.heliyon.2024.e28052","journal-title":"Heliyon"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1571231","article-title":"Prevalence and molecular insights into carbapenem resistance: a 2-year retrospective analysis of superbugs in South India","volume":"12","author":"Lathakumari RH","year":"2025","unstructured":"Lathakumari RH, Vajravelu LK, Thulukanam J, Nair DM, Vimala PB, Panneerselvam V. Prevalence and molecular insights into carbapenem resistance: a 2-year retrospective analysis of superbugs in South India. Front Med (Lausanne). 2025, 12:1571231. 10.3389\/fmed.2025.1571231","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.41.3.9978","article-title":"High ceftazidime-avibactam resistance rate in carbapenem-resistant gram-negative organisms in Pakistan's pediatric population","volume":"41","author":"Mehdi N","year":"2025","unstructured":"Mehdi N, Majeed N, Ali F, Aroob I. High ceftazidime-avibactam resistance rate in carbapenem-resistant gram-negative organisms in Pakistan's pediatric population. Pak J Med Sci. 2025, 41:788-91. 10.12669\/pjms.41.3.9978","journal-title":"Pak J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04712-8","article-title":"Prevalence and mortality of ceftazidime\/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022)","volume":"43","author":"Boattini M","year":"2024","unstructured":"Boattini M, Bianco G, Bastos P, et al.. Prevalence and mortality of ceftazidime\/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022). Eur J Clin Microbiol Infect Dis. 2024, 43:155-66. 10.1007\/s10096-023-04712-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-025-00800-z","article-title":"Diverse modes of ceftazidime\/avibactam resistance acquisition in carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa from a Chinese intensive care unit","volume":"24","author":"Zhou J","year":"2025","unstructured":"Zhou J, Chen M, Liang M, et al.. Diverse modes of ceftazidime\/avibactam resistance acquisition in carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa from a Chinese intensive care unit. Ann Clin Microbiol Antimicrob. 2025, 24:35. 10.1186\/s12941-025-00800-z","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-025-01518-5","article-title":"Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis","volume":"14","author":"Wang Y","year":"2025","unstructured":"Wang Y, Sholeh M, Yang L, Shakourzadeh MZ, Beig M, Azizian K. Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis. Antimicrob Resist Infect Control. 2025, 14:10. 10.1186\/s13756-025-01518-5","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03508-w","article-title":"Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition","volume":"24","author":"Guo Y","year":"2024","unstructured":"Guo Y, Wang J, Yao L, et al.. Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition. BMC Microbiol. 2024, 24:439. 10.1186\/s12866-024-03508-w","journal-title":"BMC Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2023.02.011","article-title":"Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco","volume":"33","author":"Perez-Palacios P","year":"2023","unstructured":"Perez-Palacios P, Girlich D, Soraa N, et al.. Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco. J Glob Antimicrob Resist. 2023, 33:208-17. 10.1016\/j.jgar.2023.02.011","journal-title":"J Glob Antimicrob Resist"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2020.100868","article-title":"Evaluating the antimicrobial resistance and frequency of AmpC \u03b2-lactamases blaCMY-2 gene in Gram-negative bacteria isolates collected from selected hospitals of Iran: A multicenter retrospective study","volume":"21","author":"Fallah F","year":"2020","unstructured":"Fallah F, Azimi T, Azimi L, et al.. Evaluating the antimicrobial resistance and frequency of AmpC \u03b2-lactamases blaCMY-2 gene in Gram-negative bacteria isolates collected from selected hospitals of Iran: A multicenter retrospective study. Gene Rep. 2020, 21:100868. 10.1016\/j.genrep.2020.100868","journal-title":"Gene Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.01.012","article-title":"Colonization by ceftazidime\/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients","volume":"29","author":"Gaibani P","year":"2023","unstructured":"Gaibani P, Bovo F, Bussini L, et al.. Colonization by ceftazidime\/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients. Clin Microbiol Infect. 2023, 29:654.e1-4. 10.1016\/j.cmi.2023.01.012","journal-title":"Clin Microbiol Infect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04197-22","article-title":"Genomic epidemiology and characterization of carbapenem-resistant Klebsiella pneumoniae in ICU inpatients in Henan province, China: a multicenter cross-sectional study","volume":"11","author":"Wang S","year":"2023","unstructured":"Wang S, Wang L, Jin J, et al.. Genomic epidemiology and characterization of carbapenem-resistant Klebsiella pneumoniae in ICU inpatients in Henan province, China: a multicenter cross-sectional study. Microbiol Spectr. 2023, 11:e0419722. 10.1128\/spectrum.04197-22","journal-title":"Microbiol Spectr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11050628","article-title":"Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in gram-negative mdr bacilli: molecular mechanisms and susceptibility testing","volume":"11","author":"Gaibani P","year":"2022","unstructured":"Gaibani P, Giani T, Bovo F, et al.. Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in gram-negative mdr bacilli: molecular mechanisms and susceptibility testing. Antibiotics (Basel). 2022, 11:628. 10.3390\/antibiotics11050628","journal-title":"Antibiotics (Basel)"},{"key":"ref22","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and dosing of antibiotics. (2019). Accessed: 2024: https:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-025-00797-5","article-title":"Clinical and microbiological characteristics of patients with ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains","volume":"24","author":"Liu SY","year":"2025","unstructured":"Liu SY, Chou SH, Chuang C, et al.. Clinical and microbiological characteristics of patients with ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains. Ann Clin Microbiol Antimicrob. 2025, 24:26. 10.1186\/s12941-025-00797-5","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02369-16","article-title":"Low frequency of ceftazidime-avibactam resistance among enterobacteriaceae isolates carrying blaKPC collected in U.S. Hospitals from 2012 to 2015","volume":"61","author":"Castanheira M","year":"2017","unstructured":"Castanheira M, Mendes RE, Sader HS. Low frequency of ceftazidime-avibactam resistance among enterobacteriaceae isolates carrying blaKPC collected in U.S. Hospitals from 2012 to 2015. Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.02369-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020153","article-title":"Assessment of in-vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant Klebsiella pneumoniae: exploring a colistin sparing protocol","volume":"11","author":"Al-Quraini M","year":"2022","unstructured":"Al-Quraini M, Rizvi M, Al-Jabri Z, et al.. Assessment of in-vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant Klebsiella pneumoniae: exploring a colistin sparing protocol. Antibiotics (Basel). 2022, 11:153. 10.3390\/antibiotics11020153","journal-title":"Antibiotics (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2023.05.012","article-title":"Plasmid-mediated AmpC in Klebsiella pneumoniae and Escherichia coli from septicaemic neonates: diversity, transmission and phenotypic detection","volume":"34","author":"Rao A","year":"2023","unstructured":"Rao A, Naha S, Bhattacharjee A, Chattopadhyay P, Dutta S, Basu S. Plasmid-mediated AmpC in Klebsiella pneumoniae and Escherichia coli from septicaemic neonates: diversity, transmission and phenotypic detection. J Glob Antimicrob Resist. 2023, 34:9-14. 10.1016\/j.jgar.2023.05.012","journal-title":"J Glob Antimicrob Resist"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02874-23","article-title":"Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185","volume":"15","author":"Kawai A","year":"2024","unstructured":"Kawai A, Shropshire WC, Suzuki M, et al.. Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185. mBio. 2024, 15:e0287423. 10.1128\/mbio.02874-23","journal-title":"mBio"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.08.020","article-title":"Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China","volume":"26","author":"Zhang P","year":"2020","unstructured":"Zhang P, Shi Q, Hu H, et al.. Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020, 26:124.e1-4. 10.1016\/j.cmi.2019.08.020","journal-title":"Clin Microbiol Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00258-24","article-title":"A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae","volume":"12","author":"Qiao S","year":"2024","unstructured":"Qiao S, Xin S, Zhu Y, et al.. A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae. Microbiol Spectr. 2024, 12:e0025824. 10.1128\/spectrum.00258-24","journal-title":"Microbiol Spectr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi S","year":"2022","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, et al.. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022, 41:1003-22. 10.1007\/s10096-020-04121-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00542-3","article-title":"Ceftazidime-avibactam-based versus tigecycline-based regimen for the treatment of carbapenem-resistant Klebsiella pneumoniae-induced pneumonia in critically ill patients","volume":"10","author":"Shi Y","year":"2021","unstructured":"Shi Y, Hu J, Liu P, et al.. Ceftazidime-avibactam-based versus tigecycline-based regimen for the treatment of carbapenem-resistant Klebsiella pneumoniae-induced pneumonia in critically ill patients. Infect Dis Ther. 2021, 10:2721-34. 10.1007\/s40121-021-00542-3","journal-title":"Infect Dis Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398316-molecular-characterization-of-kpc-2-and-cmy-ampc-beta-lactamases-in-ceftazidime-avibactam-resistant-klebsiella-pneumoniae-in-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:49:22Z","timestamp":1761652162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398316-molecular-characterization-of-kpc-2-and-cmy-ampc-beta-lactamases-in-ceftazidime-avibactam-resistant-klebsiella-pneumoniae-in-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.95576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}